QuantHealth
Tel Aviv-Yafo, Tel Aviv District, Israel · Biotechnology, Health Care, research · 60 employees
QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize
Funding history
- Funding Round — $30.0M — Oct 2025
- Series series a — $15.0M — Aug 2023
- Series seed — $2.6M — Oct 2022
Recent signals
- Mar 24, 2026: QuantHealth Appoints Nadav Weinberg as SVP of Sales and Heather Adamson as Head of Marketing
- Oct 01, 2025: Raised $30.0M
- Jan 13, 2025: QuantHealth Appoints Sharon Dagan as Chief Architect and Siwar El Assad as Chief Information Security Officer
- Dec 12, 2024: QuantHealth Partners with Atropos Health to Strengthen Trial Outcome Predictions
- Jul 02, 2024: QuantHealth Announces Partnership with OMNY Health to Improve Dataset Structures for AI Platform
- Feb 28, 2024: QuantHealth Appoints Adam Petrich as Chief Medical Officer
- Feb 07, 2024: QuantHealth Appoints Dr. Adam Petrich, MD, As Its First Chief Medical Officer and Adam Goldberger As First Chief Financial Officer
- Jan 08, 2024: Raised funding
See plans & pricing → Track QuantHealth’s funding, hiring, and signals — with verified contacts — on Fundz.